NeuroSeriesLive to Present Online CME Program on Novel Treatment Options and Individualized Therapy for Multiple Sclerosis Patients

Share Article

Recognized neurologist, Bruce Cohen, MD to present live online

News Image
The expansion of therapeutic options for MS has increased the complexity of choosing among them and determining when and how to switch between them.

November 12, 2015 - Neurologists, neurology nurses, primary care physicians, physician assistants, and nurse practitioners, who manage patients with multiple sclerosis will have an opportunity to hear neurology experts discuss novel treatment options and individualized therapies for patients with multiple sclerosis live via online video at no cost at NeuroSeriesLive. The event will be held on November 17, 2015, starting at 11:00 AM ET at The activity has been planned and implemented in accordance with requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

"The expansion of therapeutic options for MS has increased the complexity of choosing among them and determining when and how to switch between them.
For those therapies which are self-administered, adherence remains an important factor which may influence both the perceived and actual effectiveness of treatment." -Dr. Cohen

The program will feature Bruce Cohen, MD, Northwestern University Feinberg School of Medicine and Robert P. Lisak, M.D., FAAN, FRCP, Wayne State University School of Medicine. Topics in the two hour-long programs will include: Established and newer disease modifying therapies and their expected effects; Treatment selection based on all factors including clinical and patient preference; Induction or escalation for treatment-naïve patients with aggressive disease; Monitoring and clinical decision-making for patients with suboptimal response; and Challenges & recommendations for patient adherence to disease modifying therapy. This activity is supported by independent educational grants from Genzyme and Teva Pharmaceuticals.NeuroSeriesLive offers an effective way for neurologists to easily stay current on advances in care without leaving their office. There is no cost to register and watch any educational session at NeuroSeriesLive. Clinicians who attend live may take advantage of interactive capabilities like submitting questions to be addressed live online by presenting faculty and interactive polling.
To learn more and register at no cost for this live interactive video webcast, visit

About NeuroSeriesLive
NeuroSeriesLive is a leader in online CME programs in Neurology treatment and science produced by PlatformQ Health, Inc. NeuroSeriesLive enables neurologists, internal medicine specialists, family care physicians and other healthcare practitioners interested in understanding and managing patients with neurologic disorders to learn, connect and interact in real time. NeuroSeriesLive offers virtual medical education at no cost and delivers all the benefits of a physical conference, with live presentations, real-time interactive Q&A, and an exhibit floor, all from the convenience of a computer. To learn more about NeuroSeriesLive, follow us via Twitter at @NeuroSeriesLive.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mike Sweeney
since: 06/2013
Follow >
Visit website